3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uveal Melanoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Lung Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Adenoma, Islet Cell
1
Interventions
Bevacizumab
7
Capecitabine
4
Cetuximab
3
trifluridine tipiracil drug combination
2
Fluorouracil
2
regorafenib
1
irinotecan sucrosofate
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Panitumumab
1
Nivolumab
1
Liver Transplantation
1
Immune Checkpoint Inhibitors
1
HMPL-013
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
aflibercept
×
1 year
×
Clear all
No trials found.